Sheldon Preskorn is a Psychiatry physician affiliated with Wichita State University. OpenAlex indexes 1,362 publications with 12,413 citations (h-index 57); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1001 N Minneapolis
Wichita, KS 672143124
Telephone
316-293-2647Registry record last updated 4 Jan 2008.
Clinical trials
- A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Sponsor: Indiana University
- Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
Sponsor: FORUM Pharmaceuticals Inc
- Minocycline and Aspirin in the Treatment of Bipolar Depression
Sponsor: Laureate Institute for Brain Research, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20252 payments$30,400openpaymentsdata.cms.gov ↗
- BioXcel Therapeutics, Inc.Program year20251 payment
- BioXcel Therapeutics, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:
- CENTRAL ADRENERGIC SYSTEM AND BLOOD BRAIN BARRIER
University of Kansas Medical Center
FY1986R01NS023645 - CENTRAL ADRENERGIC SYSTEM AND BLOOD BRAIN BARRIER
University of Kansas Medical Center
FY1985R01NS023645
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
The International Journal of Neuropsychopharmacology
2019 - Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
Journal of Psychiatric Practice
2014
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”